Results
eNauka >
Results >
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT plus ): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
| Title: | Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT plus ): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis | Authors  : | Howard, Jr James F.; ...; Perić, Stojan Z.   ; ...; (broj koautora 17) |
Issue Date: | 2024 | Publication: | Frontiers in neurology | ISSN: | 1664-2295 Frontiers in Neurology Search Idenfier |
Publisher: | Lausanne : Frontiers Research Foundation | Type: | Article | Collation: | vol. 14 str. 1284444 | DOI: | 10.3389/fneur.2023.1284444 | WoS-ID: | 001156330800001 | Scopus-ID: | 2-s2.0-85184218524 | PMID: | 38318236 | PMCID: | PMC10842202 | URI: | https://enauka.gov.rs/handle/123456789/936653 | URL: | https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1284444/full | Project: | argenx | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21M21 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.